Evidence map›Paper›PMID 39815005›Full record

ArticleThe EMBO journal2025

The microcephaly-associated transcriptional regulator AUTS2 cooperates with Polycomb complex PRC2 to produce upper-layer neurons in mice.

Kazumi Shimaoka, Kei Hori, Satoshi Miyashita, Yukiko U Inoue, Nao K N Tabe, Asami Sakamoto, Ikuko Hasegawa, Kayo Nishitani, Kunihiko Yamashiro, Saki F Egusa and 7 more

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Kazumi ShimaokaDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.
Kei HoriDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.
Satoshi MiyashitaDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.
Yukiko U InoueDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.ORCID http://orcid.org/0000-0002-4105-9127
Nao K N TabeDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.
Asami SakamotoDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.
Ikuko HasegawaDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.
Kayo NishitaniDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.
Kunihiko YamashiroDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.
Saki F EgusaDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.
Shoji TatsumotoCognitive Genomics Research Group, Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki, Aichi, 444-8585, Japan.
Yasuhiro GoCognitive Genomics Research Group, Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki, Aichi, 444-8585, Japan.ORCID http://orcid.org/0000-0003-4581-0325
Manabu AbeDepartment of Animal Model Development, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan.ORCID http://orcid.org/0000-0001-8534-2138
Kenji SakimuraDepartment of Animal Model Development, Brain Research Institute, Niigata University, Niigata, 951-8585, Japan.
Takayoshi InoueDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan.ORCID http://orcid.org/0000-0001-7155-2150
Takuya ImamuraProgram of Biomedical Science, Graduate School of Integrated Sciences for Life, Hiroshima University, Hiroshima, 739-8526, Japan.ORCID http://orcid.org/0000-0002-1825-2084
Mikio HoshinoDepartment of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, 187-8502, Japan. hoshino@ncnp.go.jp.ORCID http://orcid.org/0000-0002-9526-3473

Funding

Japan Agency for Medical Research and Development (AMED) 24ek0109764h0001Japan Agency for Medical Research and Development (AMED) 24wm0425005h0004Japan Agency for Medical Research and Development (AMED) 24wm0625508h0001Japan Health Research Promotion Bureau (JH) 2020-B-07Japan Health Research Promotion Bureau (JH) 2024-D-01MEXT | Japan Society for the Promotion of Science (JSPS) JP16H06531MEXT | Japan Society for the Promotion of Science (JSPS) JP22H02730MEXT | Japan Society for the Promotion of Science (JSPS) JP22K15134Multilayered Stress Diseases JPMXP1323015483National Center of Neurology and Psychiatry (NCNP) 4-5National Center of Neurology and Psychiatry (NCNP) 4-6National Center of Neurology and Psychiatry (NCNP) 6-9
6 · The paper itself

Abstract

AUTS2 syndrome is characterized by intellectual disability and microcephaly, and is often associated with autism spectrum disorder, but the underlying mechanisms, particularly concerning microcephaly, remain incompletely understood. Here, we analyze mice mutated for the transcriptional regulator AUTS2, which recapitulate microcephaly. Their brains exhibit reduced division of intermediate progenitor cells (IPCs), leading to fewer neurons and decreased thickness in the upper-layer cortex. Increased expression of the AUTS2 transcriptional target Robo1 in the mutant animals suppresses IPC division, and transcriptomic and chromatin profiling shows that AUTS2 primarily represses transcription of genes like Robo1 in IPCs. Regions around the transcriptional start sites of AUTS2 target genes are enriched for the repressive histone modification H3K27me3, which is reduced in Auts2 mutants. Furthermore, we find that AUTS2 interacts with Polycomb complex PRC2, with which it cooperates to promote IPC division. These findings shed light on the microcephaly phenotype observed in the AUTS2 syndrome.

Indexed as

MicrocephalyNeuronsPolycomb Repressive Complex 2Transcription FactorsAnimalsMiceNerve Tissue ProteinsNeural Stem CellsReceptors, ImmunologicRoundabout ProteinsNerve Tissue ProteinsPolycomb Repressive Complex 2Receptors, ImmunologicRoundabout ProteinsTranscription FactorsAUTS2Histone ModificationMicrocephalyNeural ProgenitorsPolycomb

Identifiers

PMID39815005
PMCPMC11876313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.